What is a Clinical Trial?

Clinical trials follow a detailed plan, called a protocol, which guides every step of the study. This plan explains:

• The purpose of the study

• Who can participate

• What procedures will be done

• How often visits will occur

• How data will be collected and analyzed

Trials are conducted in phases (Phase 1–4), each designed to answer specific questions about the treatment, from safety to long-term effects.

Phases of a Clinical Trial (Phase 1–4)

Clinical trials are usually done in steps called phases, each designed to answer different questions:

Phase 1 – Safety Check

• Small group of volunteers

• Focuses on safety and the right dosage

• Monitors side effects closely

Phase 2 – Effectiveness

• Larger group of patients

• Tests whether the treatment works

• Continues to monitor safety

Phase 3 – Confirm Results

• Large number of patients, often at multiple locations

• Compares the new treatment to standard care

• Provides evidence for approval by regulatory authorities

Phase 4 – After Approval

• Ongoing monitoring once the treatment is available

• Tracks long-term effects and rare side effects

• Helps improve how the treatment is used in real-life settings

Tip: Each phase is carefully reviewed to protect patients and ensure reliable results.

Randomization

Patients are assigned by chance to different treatment groups to make the study fair.

In a clinical trial, randomization means that participants are assigned to different treatment groups by chance, rather than choice. This helps ensure that the groups are similar and that the results are fair and unbiased.

For example, some patients may receive the new treatment, while others receive a standard treatment or placebo. Random assignment makes it more likely that differences in outcomes are due to the treatment itself, not other factors like age, health status, or lifestyle.

The randomization process is usually handled by the study team or sponsor, so neither patients nor doctors choose which group someone is in.

Placebo

A harmless “dummy” treatment used for comparison to see if the real treatment works.

A placebo is an inactive substance or treatment that looks like the real study drug but has no therapeutic effect. Placebos are used to help researchers see whether the new treatment actually works, compared to no treatment.

In trials that use a placebo, some participants receive the study drug, and some receive the placebo. This allows doctors to compare outcomes between the two groups.

Sometimes, placebos are used alongside standard treatments, so patients are never left without care. All participants are monitored carefully for safety, and the study team knows which patients received which treatment (even if patients and doctors do not).

Protocol

The detailed plan for how the study is conducted, including schedules, procedures, and safety measures. The plan is developed by a sponsor (a dug company or a doctor in clinic). All clinics staff must adhere to the protocol. The compliance is regularly monitored by designated Clinical Trail Monitor (often called Clinical Research Associate). Protocol must always be approved by government agency (FDA in USA or EMA in Europe) before trial can begin.

Blinding

In some clinical trials, patients and/or doctors may not know which treatment group a patient is assigned to. This is done to reduce bias and ensure more reliable results.

In a single-blind study, the participant does not know which group they are in, but the doctor does. In a double-blindstudy, neither the patient nor the doctor knows the treatment assignment.

To support this process, treatments are designed to look as similar as possible—for example, an investigational drug may look the same as a placebo or standard treatment—so that it is difficult to tell them apart.

In blinded studies, the assignment is typically managed by the study sponsor (the organization developing the drug) or through a secure system. This information is kept confidential during the trial but can be accessed if needed for patient safety.

Eligibility Criteria

These are the rules that determine who can or cannot participate in a clinical trial.

They may include factors like age, type of disease, medical history, or previous treatments. These criteria help ensure that the study is safe for participants and that the results are reliable.

Adverse Event (Side Effect)

An adverse event is any unwanted or unexpected symptom or side effect that occurs during a clinical trial.

Not all adverse events are caused by the study treatment, but they are always recorded and monitored carefully to ensure patient safety.

Standard of Care

The standard of care is the treatment that is commonly used and accepted by doctors for a particular condition.

In some trials, a new treatment is compared to the standard of care to see if it works better or has fewer side effects.

Sponsor

The sponsor is the organization responsible for starting, managing, and funding the clinical trial.

This could be a pharmaceutical company, a research institution, or a government organization. The sponsor ensures the study is conducted properly and follows regulations.

Investigator / Study Doctor

The investigator (or study doctor) is the medical professional responsible for conducting the trial at a specific site.

They oversee your care during the study, monitor your health, and make sure the trial follows the protocol.

Clinical Trial Site

This is the location where the study takes place, such as a hospital, clinic, or research center.

This is where you will go for visits, tests, and treatment during the trial.

Data Monitoring / Safety Monitoring

Clinical trials are closely monitored to ensure patient safety. Independent experts may regularly review the data to check for any safety concerns.

If needed, the study can be modified or stopped to protect participants.

Withdrawal

Withdrawal means choosing to leave a clinical trial after you have already joined.

You can withdraw at any time, for any reason, without affecting your regular medical care.

Endpoint

An endpoint is what the study is measuring to determine if the treatment works.

For example, this could be improvement in symptoms, tumor size reduction, or prevention of disease progression.

Tip: The research team will always explain these clearly before you join a study.